Cargando…

Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()

Hemosiderotic fibrohistiocytic lipomatous tumors are rare neoplasms that were first described in 2000. Initially considered a benign lipotamous lesion of the soft tissues, nowadays they are considered to be a locally aggressive tumor. They occur mainly in the foot and ankle of women in their fifth a...

Descripción completa

Detalles Bibliográficos
Autores principales: Etchebehere, Renata Margarida, Almeida, Elia Cláudia Souza, Santos, Carlos David Teixeira, Micheletti, Adilha Misson Rua, Leitão, Antônio Sebastião
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497010/
https://www.ncbi.nlm.nih.gov/pubmed/28702400
http://dx.doi.org/10.1016/j.rboe.2016.11.002
_version_ 1783248082480136192
author Etchebehere, Renata Margarida
Almeida, Elia Cláudia Souza
Santos, Carlos David Teixeira
Micheletti, Adilha Misson Rua
Leitão, Antônio Sebastião
author_facet Etchebehere, Renata Margarida
Almeida, Elia Cláudia Souza
Santos, Carlos David Teixeira
Micheletti, Adilha Misson Rua
Leitão, Antônio Sebastião
author_sort Etchebehere, Renata Margarida
collection PubMed
description Hemosiderotic fibrohistiocytic lipomatous tumors are rare neoplasms that were first described in 2000. Initially considered a benign lipotamous lesion of the soft tissues, nowadays they are considered to be a locally aggressive tumor. They occur mainly in the foot and ankle of women in their fifth and sixth decades, although they may be found in any place in the lower limbs and, more rarely, in other parts of the body. Histologically, hemosiderotic fibrohistiocytic lipomatous tumors consist of a mixture of mature adipose tissue, fusiform cell fascicles, macrophages that often contain cytoplasmic hemosiderin, mononuclear inflammatory infiltrate, and stroma that may be focally myxoid. Local recurrence is observed in nearly one-third of all cases. There is no consensus in the literature whether this tumor is a part of a spectrum that comprises pleomorphic hyalinizing angiectatic tumors and myxoinflammatory fibroblastic malignant tumors, or if it is an independent entity. The authors report a case of a neoplasia after a diagnosis of a hemosiderotic fibrohistiocytic lipomatous tumor in a 38-year-old woman, with two recurrences and later sarcomatous transformation. An immunohistochemical study indicated myofibroblastic differentiation of a malignant neoplasm. To the best of the authors’ knowledge, there are only few reported cases of malignant transformation in hemosiderotic fibrohistiocytic lipomatous tumors.
format Online
Article
Text
id pubmed-5497010
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54970102017-07-12 Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report() Etchebehere, Renata Margarida Almeida, Elia Cláudia Souza Santos, Carlos David Teixeira Micheletti, Adilha Misson Rua Leitão, Antônio Sebastião Rev Bras Ortop Case Report Hemosiderotic fibrohistiocytic lipomatous tumors are rare neoplasms that were first described in 2000. Initially considered a benign lipotamous lesion of the soft tissues, nowadays they are considered to be a locally aggressive tumor. They occur mainly in the foot and ankle of women in their fifth and sixth decades, although they may be found in any place in the lower limbs and, more rarely, in other parts of the body. Histologically, hemosiderotic fibrohistiocytic lipomatous tumors consist of a mixture of mature adipose tissue, fusiform cell fascicles, macrophages that often contain cytoplasmic hemosiderin, mononuclear inflammatory infiltrate, and stroma that may be focally myxoid. Local recurrence is observed in nearly one-third of all cases. There is no consensus in the literature whether this tumor is a part of a spectrum that comprises pleomorphic hyalinizing angiectatic tumors and myxoinflammatory fibroblastic malignant tumors, or if it is an independent entity. The authors report a case of a neoplasia after a diagnosis of a hemosiderotic fibrohistiocytic lipomatous tumor in a 38-year-old woman, with two recurrences and later sarcomatous transformation. An immunohistochemical study indicated myofibroblastic differentiation of a malignant neoplasm. To the best of the authors’ knowledge, there are only few reported cases of malignant transformation in hemosiderotic fibrohistiocytic lipomatous tumors. Elsevier 2016-11-16 /pmc/articles/PMC5497010/ /pubmed/28702400 http://dx.doi.org/10.1016/j.rboe.2016.11.002 Text en © 2016 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Etchebehere, Renata Margarida
Almeida, Elia Cláudia Souza
Santos, Carlos David Teixeira
Micheletti, Adilha Misson Rua
Leitão, Antônio Sebastião
Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
title Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
title_full Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
title_fullStr Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
title_full_unstemmed Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
title_short Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
title_sort sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497010/
https://www.ncbi.nlm.nih.gov/pubmed/28702400
http://dx.doi.org/10.1016/j.rboe.2016.11.002
work_keys_str_mv AT etchebehererenatamargarida sarcomatoustransformationofahemosideroticfibrohistiocyticlipomatoustumoracasereport
AT almeidaeliaclaudiasouza sarcomatoustransformationofahemosideroticfibrohistiocyticlipomatoustumoracasereport
AT santoscarlosdavidteixeira sarcomatoustransformationofahemosideroticfibrohistiocyticlipomatoustumoracasereport
AT michelettiadilhamissonrua sarcomatoustransformationofahemosideroticfibrohistiocyticlipomatoustumoracasereport
AT leitaoantoniosebastiao sarcomatoustransformationofahemosideroticfibrohistiocyticlipomatoustumoracasereport